Thus, further evidence of platelet activation in MS was provided by the demonstration of significant elevation of P-selectin in a study which compared 33 treatment-naïve, clinically stable RR-MS patients, with 92 control subjects using flow cytometry (65). Here, SELP is linked to myeloid sarcoma.